OL
Optceutics Limited
optceutics.com
Website unreachable since Oct 27, 2026
The startup has developed a dynamic pharmacokinetic model specifically for retinal diseases, which optimizes dose selection and frequency while comparing drug activity and duration against existing products. This approach minimizes risks and costs associated with preclinical and clinical studies, enabling pharmaceutical companies to efficiently refine retinal drug formulations.
- Biotechnology
Updated 6 months ago
Funding
Raised to date
$480KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a dynamic pharmacokinetic model specifically for retinal diseases, which optimizes dose selection and frequency while comparing drug activity and duration against existing products. This approach minimizes risks and costs associated with preclinical and clinical studies, enabling pharmaceutical companies to efficiently refine retinal drug formulations.